title: BPRS syndrome scales during the course of an episode of psychiatric illness.
abstract: This report examines changes in symptom levels on the four major syndrome scales from the Brief Psychiatric Rating Scale (BPRS): thought disturbance, paranoid disturbance, anxiety/depression, and emotional withdrawal/motor retardation. Baseline BPRS ratings were obtained during the first week of hospitalization for an acute episode of psychiatric illness, in 120 patients with schizophrenia, schizoaffective disorder, and depression. BPRS ratings were carried out in the week prior to discharge. Findings indicated that patients with schizoaffective disorder showed a greater magnitude of general clinical improvement than schizophrenics, although both groups had comparable improvement on thought disorder from admission to discharge. Paranoid symptoms did not recover as completely among schizophrenics compared to schizoaffective disorder patients. As expected, anxiety and depression symptoms remitted most prominently among the depressed inpatients.
authors.affiliation: Department of Psychology, Long Island University, Brookville NY 11548, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Silverstein
authors.forename: G
authors.initials: G
authors.lastname: Mavrolefteros
authors.forename: D
authors.initials: D
authors.lastname: Close
mesh_terms: D000208:Acute Disease; D010054:Brief Psychiatric Rating Scale / Q000706:statistics & numerical data*; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D006760:Hospitalization; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis* / Q000188:drug therapy; D015999:Multivariate Analysis; D011594:Psychometrics; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy; D012565:Schizophrenic Psychology; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D011619:Psychotropic Drugs